Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with biopharma for the development of novel antibody therapeutics. As a proven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results